Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:33 AM
Ignite Modification Date:
2025-12-25 @ 1:33 AM
NCT ID:
NCT02343094
Eligibility Criteria:
Inclusion Criteria:
* Chronic Kidney disease for ore than 3 months
* Proteinuria \> 1g/d or 0,1g/mmmol creatinine
* eGFR \>30ml/mn/1,73m2
* written informed consent
* affiliated with social security health insurance
Exclusion Criteria:
* Women with childbearing potential
* Recent (\<3 months) modification of ACE inhibitors or ARB
* Acute renal failure
* eGFR \<30ml/mn/1,73m2
* Nephrotic syndrome (albuminélia \<30g/l)
* Infection with HIV, HCV, HBV
* Liver insufficiency
* No affiliated with social security health insurance
* inclusion in another protocol of biomedical research
* risk of non-adherence to protocol and visits
* patients having a cardiac insufficiency of grade 3 or 4
* patient requiring of a strict salt-free diet
* patients under corticoids or immunosuppresseurs
* clinical intolerance in the treatment
* intolerance in the fructose, the syndrome of malabsorption glucose and galactose or a deficit in sucrase / isomaltase
* patients treated by Probenecide
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02343094
Study Brief:
Protocol Section:
NCT02343094